Spebrutinib T2603
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Spebrutinib is an orally bioavailable, selective inhibitor of Bruton's agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
CAS nr:
1202757-89-8
Purity:
98%
Molecular Weight:
423,44
SMILES:
COCCOC1=CC=C(NC2=NC=C(F)C(NC3=CC(NC(=O)C=C)=CC=C3)=N2)C=C1
Formula:
C22H22FN5O3
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
BTK,BTK,Src,Src
